Abstract
A series of 24 novel triazole-linked flavonol glycoconjugates 1~24 were synthesized using flavonols (Kaempferol, Rhamnocitrin or 7,5,4’-trimethoxy flavonol) and carbohydrates (glucose, galactose, lactose or maltose) as starting materials by a “Click chemistry” approach. Intermolecular Cu (I) catalyzed 1,3-dipolar cycloaddition of propargyl ethers of flavonols and glycosyl azides is the key step. Their cytotoxic potential against four human cancer cell lines (HL- 60, SMMC-7721, A-549 and MCF-7) was evaluated by standard MTT method. The results showed that 1, 3, 5, 6, 12 and 13 exhibit moderate to potent cytotoxicity against these cancer cell lines comparable with the positive control, cis- Platinum (DDP).
Keywords: Cytotoxic activity, Click chemistry, Flavonol, Glycoconjugates.
Letters in Organic Chemistry
Title:A Facile “Click Chemistry” Approach to Novel Flavonol Glycoconjugates and Their Cytotoxic Activity
Volume: 10 Issue: 9
Author(s): Wu Zheng, Nguyen Van-son, Liu Zhang-kun and Wang Qiu-an
Affiliation:
Keywords: Cytotoxic activity, Click chemistry, Flavonol, Glycoconjugates.
Abstract: A series of 24 novel triazole-linked flavonol glycoconjugates 1~24 were synthesized using flavonols (Kaempferol, Rhamnocitrin or 7,5,4’-trimethoxy flavonol) and carbohydrates (glucose, galactose, lactose or maltose) as starting materials by a “Click chemistry” approach. Intermolecular Cu (I) catalyzed 1,3-dipolar cycloaddition of propargyl ethers of flavonols and glycosyl azides is the key step. Their cytotoxic potential against four human cancer cell lines (HL- 60, SMMC-7721, A-549 and MCF-7) was evaluated by standard MTT method. The results showed that 1, 3, 5, 6, 12 and 13 exhibit moderate to potent cytotoxicity against these cancer cell lines comparable with the positive control, cis- Platinum (DDP).
Export Options
About this article
Cite this article as:
Zheng Wu, Van-son Nguyen, Zhang-kun Liu and Qiu-an Wang, A Facile “Click Chemistry” Approach to Novel Flavonol Glycoconjugates and Their Cytotoxic Activity, Letters in Organic Chemistry 2013; 10 (9) . https://dx.doi.org/10.2174/15701786113109990039
DOI https://dx.doi.org/10.2174/15701786113109990039 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Aldose Reductase: A Multi-disease Target
Current Enzyme Inhibition Targeting PPAR Isoforms Following CNS Injury
Current Drug Targets Host Innate Immune Responses to Microbial Pathogens
Current Vascular Pharmacology Bioactivity and Pharmacological Actions of Carbon Monoxide-Releasing Molecules
Current Pharmaceutical Design Ghrelin and Motilin in the Gastrointestinal System
Current Pharmaceutical Design Drug-Eluting Stents: Present and Future
Cardiovascular & Hematological Agents in Medicinal Chemistry Cross-Talk Between TGF-β and NADPH Oxidases During Liver Fibrosis and Hepatocarcinogenesis
Current Pharmaceutical Design Mechanisms, Prevention and Treatment of Distal Embolization
Current Pharmaceutical Design Aging is Neuroprotective During Global Ischemia but Leads to Increased Caspase-3 and Apoptotic Activity in Hippocampal Neurons
Current Neurovascular Research Adiponectin and its Role in Cardiovascular Diseases
Cardiovascular & Hematological Disorders-Drug Targets Irreversible Inhibition of Serine Proteases – Design and In Vivo Activity of Diaryl α-Aminophosphonate Derivatives
Current Medicinal Chemistry Safflor Protected Rat Cerebral Ischemia-Reperfusion Injury Through Inhibiting the Expression of NF-kB and IL-1β
Neuroscience and Biomedical Engineering (Discontinued) Sildenafil Improves Vascular Endothelial Structure and Function in Renovascular Hypertension
Current Pharmaceutical Biotechnology Brain Injury Associated with Widely Abused Amphetamines: Neuroinflammation, Neurogenesis and Blood-Brain Barrier
Current Drug Abuse Reviews Relevance of Nutritional Antioxidants in Metabolic Syndrome, Ageing and Cancer: Potential for Therapeutic Targeting
Infectious Disorders - Drug Targets Peptide5 Attenuates rtPA Related Brain Microvascular Endothelial Cells Reperfusion Injury via the Wnt/β-Catenin Signalling Pathway
Current Neurovascular Research Perspective of Molecular Hydrogen in the Treatment of Sepsis
Current Pharmaceutical Design Editorial [Hot topic: Stroke as a Target in Medicinal Chemistry and Drug Discovery (Guest Editor: Antonino Tuttolomondo)]
Current Topics in Medicinal Chemistry Evaluation of Pharmacological Treatment Strategies in Traumatic Brain Injury
Current Pharmaceutical Design Cardiac Calmodulin Kinase: A Potential Target for Drug Design
Current Medicinal Chemistry